{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:32:03Z","timestamp":1791606723121,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jhep.2022.02.020","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:59:09Z","timestamp":1646477949000},"page":"525-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-5840","authenticated-orcid":false,"given":"Adam J.","family":"Gehring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-307X","authenticated-orcid":false,"given":"Patricia","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9795-5206","authenticated-orcid":false,"given":"Hildegund","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric F.","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4161-9462","authenticated-orcid":false,"given":"Mala","family":"Maini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-1616","authenticated-orcid":false,"given":"Andre","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9792-4271","authenticated-orcid":false,"given":"Georg","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"de Creus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Ferrando","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1222-5317","authenticated-orcid":false,"given":"Jessica","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-682X","authenticated-orcid":false,"given":"Emily","family":"Gainor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.02.020_bib1","article-title":"Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference","author":"Cornberg","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.02.020_bib2","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the liver by intravascular effector CD8(+) T cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2022.02.020_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib5","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2022.02.020_bib6","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib7","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2022.02.020_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2022.02.020_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","article-title":"Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection","volume":"68","author":"Hoogeveen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.020_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2020.04.019","article-title":"Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection","volume":"159","author":"Le Bert","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.020_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B virus--specific and global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.020_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.020_bib13","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2022.02.020_bib14","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2022.02.020_bib15","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1128\/JVI.01124-08","article-title":"Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire","volume":"82","author":"Tan","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2017.05.014","article-title":"Effect of the anticoagulant, storage time and temperature of blood samples on the concentrations of 27 multiplex assayed cytokines \u2013 consequences for defining reference values in healthy humans","volume":"97","author":"Henn\u00f8","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jhep.2022.02.020_bib17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.174.6.1565","article-title":"Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen","volume":"174","author":"Penna","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2022.02.020_bib18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1172\/JCI92812","article-title":"Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation","volume":"128","author":"Rivino","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2022.02.020_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.gastro.2019.03.044","article-title":"Combined GS-4774 and tenofovir therapy can improve HBV-specific T-cell responses in patients with chronic hepatitis","volume":"157","author":"Boni","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.020_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bpg.2017.05.004","article-title":"New treatments to reach functional cure: rationale and challenges for emerging immune-based therapies","volume":"31","author":"Gehring","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2022.02.020_bib21","doi-asserted-by":"crossref","first-page":"100361","DOI":"10.1016\/j.jhepr.2021.100361","article-title":"Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib\/IIa study","volume":"3","author":"Ma","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2022.02.020_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.020_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0168-8278(03)00292-7","article-title":"Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B","volume":"39","author":"Boni","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.020_bib24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1099\/0022-1317-83-6-1267","article-title":"Genetic variability in hepatitis B viruses","volume":"83","author":"Kidd-Ljunggren","year":"2002","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jmv.10425","article-title":"Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity","volume":"70","author":"Vanlandschoot","year":"2003","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib26","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1099\/0022-1317-83-9-2279","article-title":"LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles","volume":"83","author":"Vanlandschoot","year":"2002","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B","volume":"72","author":"Le Bert","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.020_bib28","doi-asserted-by":"crossref","first-page":"11344","DOI":"10.1038\/s41598-020-68226-5","article-title":"Optimized ex\u00a0vivo stimulation identifies multi-functional HBV-specific T cells in a majority of chronic hepatitis B patients","volume":"10","author":"Chua","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.02.020_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2009.02.007","article-title":"Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses","volume":"344","author":"Almeida","year":"2009","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jhep.2022.02.020_bib30","series-title":"2019 International HBV Meeting. Melbourne, Australia","article-title":"Comprehensive assessment of novel HBV T cell epitopes suggests a partial recovery of CD4-specific T cells following HBs seroconversion in chronic patients","author":"Hoogeveen","year":"2019"},{"key":"10.1016\/j.jhep.2022.02.020_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6905","article-title":"Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection","volume":"4","author":"Cheng","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhep.2022.02.020_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1034\/j.1399-0039.1999.530401.x","article-title":"HLA class I allele distributions in six Pacific\/Asian populations: evidence of selection at the HLA-A locus","volume":"53","author":"Bugawan","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhep.2022.02.020_bib33","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1301507","article-title":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity","volume":"191","author":"Rivino","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2022.02.020_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01663-19","article-title":"Discovery and selection of hepatitis B virus-derived T cell epitopes for global immunotherapy based on viral indispensability, conservation, and HLA-binding strength","volume":"94","author":"de Beijer","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib35","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2021.06.013","article-title":"Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma","volume":"54","author":"Cheng","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2022.02.020_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nmeth.1345","article-title":"Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers","volume":"6","author":"Hadrup","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhep.2022.02.020_bib37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2019.02.016","article-title":"OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection","volume":"70","author":"Jacobi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.020_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105703","article-title":"Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules","volume":"9","author":"Raziorrouh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2022.02.020_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejim.2011.09.001","article-title":"Should we routinely treat patients with autoimmune\/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes","volume":"22","author":"Vassilopoulos","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2022.02.020_bib40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jhep.2017.10.027","article-title":"Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B","volume":"68","author":"Janssen","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.020_bib41","article-title":"The inflammatory cytokine profile associated with liver damage is broader and stronger in chronic hepatitis B Patients compared to acute hepatitis B patients","author":"Johnson Valiente","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhep.2022.02.020_bib42","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1038\/s41598-019-50729-5","article-title":"Soluble immune markers in the different phases of chronic hepatitis B virus infection","volume":"9","author":"Wiegand","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.02.020_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2022.02.020_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2022.02.020_bib45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2022.02.020_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2022.02.020_bib47","first-page":"13","article-title":"Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection","author":"Nishio","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2022.02.020_bib48","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2018.01.030","article-title":"TLR7 agonist increases responses of hepatitis B virus-specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(T)ide analogues","volume":"154","author":"Boni","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.020_bib49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","article-title":"Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity","volume":"40","author":"Xu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2022.02.020_bib50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-021-03351-3","article-title":"Expansible residence decentralizes immune homeostasis","volume":"592","author":"Wijeyesinghe","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.02.020_bib51","series-title":"Clinical implementation of single-cell RNA sequencing using liver fine needle aspirate tissue sampling and centralized processing captures compartment specific immuno-diversity","author":"Genshaft","year":"2021"},{"key":"10.1016\/j.jhep.2022.02.020_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-314873","article-title":"Liver sampling: a vital window into HBV pathogenesis on the path to functional cure","author":"Gill","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.020_bib53","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2018-317071","article-title":"Fine needle aspirates comprehensively sample intrahepatic immunity","volume":"68","author":"Gill","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.020_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2015.04.011","article-title":"Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liver","volume":"424","author":"Pembroke","year":"2015","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jhep.2022.02.020_bib55","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/eji.201445369","article-title":"High-resolution determination of human immune cell signatures from fine-needle liver aspirates","volume":"45","author":"Hengst","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2022.02.020_bib56","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1128\/JVI.02551-10","article-title":"Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans","volume":"85","author":"Claassen","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.02.020_bib57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gutjnl-2013-304472","article-title":"The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon alpha treatment","volume":"63","author":"Pembroke","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.020_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2015.09.006","article-title":"Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy","volume":"123","author":"Spaan","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2022.02.020_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2016.05.016","article-title":"Similar frequencies, phenotype and activation status of intrahepatic NK cells in chronic HBV patients after long-term treatment with tenofovir disoproxil fumarate (TDF)","volume":"132","author":"Tjwa","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2022.02.020_bib60","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2022.02.020_bib61","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146883","article-title":"Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver","volume":"6","author":"Traum","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhep.2022.02.020_bib62","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cell.2020.05.006","article-title":"Host-viral infection maps reveal signatures of severe COVID-19 patients","volume":"181","author":"Bost","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2022.02.020_bib63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A\u00a0human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"Aizarani","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.02.020_bib64","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.02.020_bib65","series-title":"U.S. Department of Health and Human Services FaDA, Center for Devices and Radiological Health","article-title":"Requests for feedback and meetings for medical device submissions: the Q-submission program. Guidance for industry and food and drug administration staff","year":"2021"},{"key":"10.1016\/j.jhep.2022.02.020_bib66","article-title":"Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection","author":"Aliabadi","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhep.2022.02.020_bib67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41590-020-00817-w","article-title":"Memory-like HCV-specific CD8 + T cells retain a molecular scar after cure of chronic HCV infection","volume":"22","author":"Hensel","year":"2021","journal-title":"Nat Immunol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:46:01Z","timestamp":1759175161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0168827822001271"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.02.020","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741794280.793592195","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}